Signal management

Envestnet Asset Management Inc. sells 7,312 shares of Masimo Co. (NASDAQ:MASI)


Envestnet Asset Management Inc. cut its stake in Masimo Co. (NASDAQ:MASI – Get Rating) by 19.5% during the 1st quarter, according to the company in its latest SEC filing. The institutional investor held 30,253 shares of the medical equipment supplier after selling 7,312 shares during the quarter. Envestnet Asset Management Inc. owned 0.05% of Masimo worth $4,403,000 at the end of the last quarter.

Several other large investors have also increased or reduced their stake in the company. Allspring Global Investments Holdings LLC purchased a new stake in Masimo stock during Q4 for approximately $647,000. Fifth Third Bancorp increased its holdings of Masimo shares by 60.3% during the fourth quarter. Fifth Third Bancorp now owns 218 shares of the medical equipment supplier worth $64,000 after acquiring 82 more shares in the last quarter. Oppenheimer & Co. Inc. increased its stake in Masimo shares by 111.6% during the 4th quarter. Oppenheimer & Co. Inc. now owns 3,781 shares of the medical equipment supplier worth $1,107,000 after acquiring 1,994 additional shares in the last quarter. DekaBank Deutsche Girozentrale increased its position in Masimo by 18.3% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 7,312 shares of the medical equipment supplier worth $2,104,000 after buying an additional 1,130 shares during the period. Finally, Sigma Planning Corp increased its position in Masimo by 22.2% in the 4th quarter. Sigma Planning Corp now owns 2,905 shares of the medical equipment supplier worth $851,000 after buying an additional 528 shares during the period. Institutional investors hold 92.03% of the company’s shares.

Masimo stock up 0.8%

Masimo stock opened Friday at $154.37. Masimo Co. has a 1-year low of $112.07 and a 1-year high of $305.21. The company has a debt ratio of 0.77, a current ratio of 2.10 and a quick ratio of 3.98. The stock has a market capitalization of $8.57 billion, a PE ratio of 46.50 and a beta of 0.98. The stock’s fifty-day moving average is $137.78 and its two-hundred-day moving average is $148.47.

Masimo (NASDAQ:MASI – Get Rating) last released its quarterly results on Tuesday, August 9. The medical equipment supplier reported earnings per share (EPS) of $1.35 for the quarter, beating analysts’ consensus estimate of $1.19 by $0.16. Masimo had a return on equity of 17.39% and a net margin of 12.68%. The company posted revenue of $565.30 million for the quarter, versus analyst estimates of $540.56 million. In the same quarter last year, the company posted earnings per share of $0.94. The company’s revenue increased 87.9% year over year. On average, sell-side analysts expect Masimo Co. to post EPS of 4.46 for the current fiscal year.

Analysts set new price targets

MASI has been the subject of several research analyst reports. StockNews.com upgraded Masimo’s shares from a “buy” rating to a “hold” rating in a research report on Wednesday. Stifel Nicolaus reduced his price target on Masimo from $175.00 to $150.00 in a Wednesday, May 4 report. Needham & Company LLC raised its price target on Masimo from $163.00 to $179.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Piper Sandler raised her price target on Masimo from $130.00 to $135.00 and gave the company a “neutral” rating in a report released Wednesday. Four research analysts gave the stock a hold rating and three gave the company a buy rating. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $183.80.

Masimo Profile

(Get an assessment)

Masimo Corporation develops, manufactures and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers pulse oximetry based on Masimo Signal Extraction Technology (SET) with measurement motion and low perfusion pulse oximetry monitoring to address key limitations of conventional pulse oximetry.

Featured articles

Want to see what other hedge funds hold MASI? Visit HoldingsChannel.com for the latest 13F filings and insider trading for Masimo Co. (NASDAQ:MASI – Get Rating).

Institutional ownership by quarter for Masimo (NASDAQ: MASI)



Get news and reviews for Masimo Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Masimo and related companies with MarketBeat.com’s free daily email newsletter.